Biocept Inc: Overview

Biocept Inc (Biocept) is a molecular diagnostics company. It develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. The company offers assays for solid tumor indications, including breast cancer, non-small cell lung cancer, small cell lung cancer, gastric cancer, colorectal cancer, prostate cancer, melanoma, pancreatic biliary cancer and ovarian cancer. Biocept offers related instrumentation, OncoCEE technology, and analytical capabilities for rare event detection and genetic characterization. The company’s OncoCEE, Target Selector, and CEE-Sure, platform modifies rare cell capture and analysis methods. It also serves cancer diagnostic assays to oncologists and other physicians, hospitals and cancer centers. Biocept also provides clinical trial and research services to pharmaceutical and biopharmaceutical companies and clinical research organizations. Biocept is headquartered in San Diego, California, the US.